Cargando…

Isolated and Spontaneous Correction of Proximal Interphalangeal Joint Contractures in Dupuytren’s Disease: An Exploratory Analysis of the Efficacy and Safety of Collagenase Clostridium histolyticum

BACKGROUND AND OBJECTIVE: Dupuytren’s contractures affecting proximal interphalangeal (PIP) joints are challenging to treat. We explored the effects of collagenase Clostridium histolyticum (CCH) on PIP joint contractures after injection of an affected metacarpophalangeal (MP) joint in the same finge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayton, Michael J., Bayat, Ardeshir, Chapman, Douglass S., Gerber, Robert A., Szczypa, Piotr P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2013
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830197/ https://www.ncbi.nlm.nih.gov/pubmed/24092562 http://dx.doi.org/10.1007/s40261-013-0139-0

Ejemplares similares

Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015)

The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
por: Thomas, Alexis, et al.
Publicado: (2010)

Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up
por: Nayar, Suresh K., et al.
Publicado: (2019)

Collagenase clostridium histolyticum in patients with Dupuytren’s contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes
por: Warwick, D., et al.
Publicado: (2015)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
por: Noto, Kimitoshi, et al.
Publicado: (2019)

Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy
por: Divino, Victoria M., et al.
Publicado: (2020)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
por: Coleman, Stephen, et al.
Publicado: (2012)

Postapproval clinical experience in the treatment of Dupuytren’s contracture with collagenase clostridium histolyticum (CCH): the first 1,000 days
por: Schulze, Scott M., et al.
Publicado: (2014)

Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Retraction: Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

The use of Collagenase Clostridium Histolyticum in the management of Dupuytren’s contracture-outcomes of a pilot study in a District General Hospital setting
por: Murphy, Lynn E, et al.
Publicado: (2017)

Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis
por: Zah, Vladimir, et al.
Publicado: (2020)

Incidence of Tendon Rupture After Collagenase Clostridium Histolyticum Injection for Treatment of Dupuytren Contracture in Adults: A Postmarketing Safety Analysis
por: Peimer, Clayton A., et al.
Publicado: (2022)

Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis [Corrigendum]
Publicado: (2021)

Long-Term Outcomes of Collagenase Clostridium Histolyticum Injection for Palmar Dupuytren’s Deformity Correction
por: Kasture, Sarang, et al.
Publicado: (2021)

Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial
por: Costas, Bronier, et al.
Publicado: (2017)

Prospective observation of Clostridium histolyticum collagenase for the treatment of Dupuytren’s disease in 788 patients: the Austrian register
por: Rohit, Arora, et al.
Publicado: (2019)

Clostridium Histolyticum Collagenase Underdosed for Multicord Injection in Dupuytren’s Disease: A Retrospective Cohort Study
por: Boriani, Filippo, et al.
Publicado: (2022)

Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture
por: Bainbridge, Chris, et al.
Publicado: (2012)

Collagenase Clostridium histolyticum Injection Therapy Improves Health-related Quality of Life in Patients with Dupuytren’s Disease
por: Kuboi, Takuro, et al.
Publicado: (2021)

Role of collagenase clostridium histolyticum in Peyronie’s disease
por: Peak, Taylor C, et al.
Publicado: (2015)

Isolated Small Finger Distal Interphalangeal Joint Dupuytren's Contracture
por: Mehdi, Syed K., et al.
Publicado: (2019)

Monitoring the Degradation of Collagen Hydrogels by Collagenase Clostridium histolyticum
por: Ng, Hon Wei, et al.
Publicado: (2020)

First Identification of Resident and Circulating Fibrocytes in Dupuytren’s Disease Shown to Be Inhibited by Serum Amyloid P and Xiapex
por: Iqbal, Syed Amir, et al.
Publicado: (2014)

Short-term efficacy and adverse effects of collagenase clostridium histolyticum injections, percutaneous needle fasciotomy and limited fasciectomy in the treatment of Dupuytren’s contracture: a network meta-analysis of randomized controlled trials
por: Obed, Doha, et al.
Publicado: (2022)

Collagenase Clostridium histolyticum : emerging practice patterns and treatment advances
por: Warwick, David, et al.
Publicado: (2016)

New Considerations in the Use of Collagenase Clostridium Histolyticum for the Treatment of Cellulite
por: Grekin, Jeremy A, et al.
Publicado: (2023)

Cost-Effectiveness and Patient Outcomes of Injectable Collagenase to Treat Dupuytren’s Contracture
por: Sahemey, Rajpreet S, et al.
Publicado: (2021)

Botulinum toxin as an adjunct for severe Dupuytren’s contracture treated with collagenase injections
por: Denkler, Keith A., et al.
Publicado: (2022)

Intralesional collagenase clostridium histolyticum study provides real-world analysis
por: Haney, Nora M., et al.
Publicado: (2016)

Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
por: Kuhlmann, Paige K, et al.
Publicado: (2017)

Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue
por: Fischer, Sebastian, et al.
Publicado: (2016)

Needle Fasciotomy or Collagenase Injection in the Treatment of Dupuytren’s Contracture: A Retrospective Study
por: Abdelrahman, Islam, et al.
Publicado: (2020)

AB041. Experience in the use of collagenase clostridium histolyticum in the management of Peyronie’s disease
por: Jad, Amr, et al.
Publicado: (2016)

Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie’s disease
por: Nguyen, Hoang Minh Tue, et al.
Publicado: (2017)

The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie's Disease in the United States
por: Sun, Andrew J., et al.
Publicado: (2019)

Efficacy, Safety, and Durability of Response of Collagenase Clostridium Histolyticum-aaes for Treating Cellulite
por: Kaufman-Janette, Joely A., et al.
Publicado: (2020)

Peyronie’s disease – outcomes of collagenase clostridium histolyticum injection: A systematic review
por: Mefford, Austin T., et al.
Publicado: (2021)

Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s disease
por: Gannon, Margaret K., et al.
Publicado: (2021)

Evaluation of alternative diluents for clinical use of collagenase clostridium histolyticum (CCH‐aaes)
por: Wolfe, Henry R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d8cdlrbdtquc06u7skbhhcsafp